Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:1353-1361
Published online before print August 22, 2005, doi: 10.1161/CIRCULATIONAHA.104.519025
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
112/9/1353    most recent
CIRCULATIONAHA.104.519025v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, S.
Right arrow Articles by Dong, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, S.
Right arrow Articles by Dong, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AZACITIDINE
*LACTIC ACID
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Pathophysiology
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Ion channels/membrane transport
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2005;112:1353-1361.)
© 2005 American Heart Association, Inc.


Vascular Medicine

Inactivation of Monocarboxylate Transporter MCT3 by DNA Methylation in Atherosclerosis

Shoukang Zhu, MD, MSc; Pascal J. Goldschmidt-Clermont, MD; Chunming Dong, MD

From the Department of Internal Medicine, Duke University Medical Center, Durham, NC.

Correspondence to Chunming Dong, MD, Department of Medicine, Duke University Medical Center, Box 3845, Durham, NC 27710. E-mail dong0005{at}mc.duke.edu

Received November 5, 2004; revision received May 16, 2005; accepted May 18, 2005.

Background— Monocarboxylate transporters (MCTs) mediate lactate transport across the plasma membrane of cells. The molecular mechanisms regulating monocarboxylate transport in smooth muscle cells (SMCs) remain poorly characterized. The aim of this study was to investigate the effects of DNA methylation on MCT expression and lactate transport in SMCs in relation to atherosclerosis.

Methods and Results— MCT expression was determined by real-time reverse transcription–polymerase chain reaction, Western blotting, and immunohistochemistry in SMCs isolated from human aortas and coronary arteries. Bisulfite sequencing and confocal microscopic analysis were used to study DNA methylation and lactate transport in SMCs, respectively. Downregulation of MCT3 and impaired lactate transport were detected in proliferating/synthetic SMCs, relative to the contractile phenotype. A passage number– and atherosclerotic lesion–dependent methylation pattern of MCT3 was demonstrated in the CpG island located in exon 2. Treatment of SMCs with the demethylating agent 5-aza-2'-deoxycytidine restored MCT3 expression and normalized lactate transport. Furthermore, small interfering RNA–mediated specific MCT3 knockdown substantially stimulated SMC proliferation.

Conclusions— These data indicate that DNA methylation may modify monocarboxylate transport by suppressing MCT3 expression, which could be important in regulating SMC function and the development of atherosclerosis.


Key Words: atherosclerosis • cardiovascular diseases • ion channels • molecule biology • muscle, smooth